Get the Stockscreener App
8.59
0.82%
0.07
After Hours:
8.59
Biocryst Pharmaceuticals Inc Stock (BCRX) Forecast
The Biocryst Pharmaceuticals Inc (BCRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.06, representing a +63.72% increase from the current price of $8.59. The highest analyst price target is $15.77, and the lowest is $12.35.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCRX Price Target
Average 11.28
(+31.30% Upside)
Is Biocryst Pharmaceuticals Inc (BCRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.40 | Neutral |
| STOCH(9,6) | 57.24 | Neutral |
| STOCHRSI(14) | 82.90 | Sell |
| MACD(12,26) | -0.276 | Sell |
| ADX(14) | 19.74 | Neutral |
| William %R | -58.70 | Neutral |
| CCI(14) | -1.9423 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.542
Buy
|
8.6607
Sell
|
| MA20 |
8.968
Sell
|
8.8759
Sell
|
| MA50 |
9.3302
Sell
|
9.1764
Sell
|
| MA100 |
9.2525
Sell
|
9.1548
Sell
|
| MA200 |
8.6648
Sell
|
8.9685
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BCRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BCRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.4 indicates that BCRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.24 indicates that BCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 82.9 indicates that BCRX is oversold. This suggests that BCRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.74 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -1.9423 indicates that BCRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BCRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biocryst Pharmaceuticals Inc financial reports and earnings history, Biocryst Pharmaceuticals Inc (BCRX) stock could reach $3.0515 by 2030, $2.1187 by 2040 and $5.9202 by 2050. See the projected annual prices until 2050 of the Biocryst Pharmaceuticals Inc stock below:
- Biocryst Pharmaceuticals Inc (BCRX) is expected to reach an average price of $1.4079 in 2035, with a high prediction of $2.4444 and a low estimate of $0.6939. This indicates an $-83.61% rise from the last recorded price of $8.59.
- Biocryst Pharmaceuticals Inc (BCRX) stock is projected to chart a bullish course in 2040, with an average price target of $0.9572, representing an $-88.86% surge from its current level. The forecast ranges from a conservative $0.5329 to a sky-high $2.1187.
- Our analysts predict Biocryst Pharmaceuticals Inc (BCRX) to jump -51.54% by 2045, soaring from $2.4944 to an average price of $4.1624, potentially reaching $4.9674. While $2.4944 is the low estimate, the potential upside is significant.
- Biocryst Pharmaceuticals Inc (BCRX) stock is expected to climb by 2050, reaching an average of $3.5639, a $-58.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.9202 and $1.7739, respectively, highlighting the market's uncertainty.
Biocryst Pharmaceuticals Inc Stock (BCRX) Year by Year Forecast
Biocryst Pharmaceuticals Inc Stock (BCRX) Price Forecast for 2026
The predicted value for Biocryst Pharmaceuticals Inc (BCRX) in 2026 is set at an average of $8.2882. Estimates vary from a peak of $15.77 to a trough of $0.8034, indicating an -3.51% surge from the present price of $8.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $14.90 | $12.35 | $15.77 | +73.49% |
| November, 2026 | $13.23 | $11.30 | $15.42 | +54.04% |
| December, 2026 | $11.72 | $11.54 | $13.54 | +36.39% |
Biocryst Pharmaceuticals Inc Stock (BCRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biocryst Pharmaceuticals Inc (BCRX) is $11.28, with a high forecast of $17.44 and a low forecast of $5.1216. This indicates an +31.30% increase from the last price of $8.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.06 | $10.45 | $12.94 | +40.45% |
| February, 2027 | $9.2638 | $8.7138 | $13.12 | +7.84% |
| March, 2027 | $10.43 | $8.1128 | $10.60 | +21.39% |
| April, 2027 | $12.90 | $8.9668 | $14.77 | +50.13% |
| May, 2027 | $12.65 | $10.29 | $13.56 | +47.21% |
| June, 2027 | $13.56 | $12.58 | $17.44 | +57.85% |
| July, 2027 | $13.74 | $11.90 | $16.06 | +59.93% |
| August, 2027 | $7.1673 | $7.0373 | $15.49 | -16.56% |
| September, 2027 | $7.2811 | $5.1216 | $7.9368 | -15.24% |
| October, 2027 | $7.1601 | $6.0801 | $8.8553 | -16.65% |
| November, 2027 | $9.6391 | $6.7348 | $9.8941 | +12.21% |
| December, 2027 | $12.22 | $8.1333 | $13.01 | +42.29% |
Biocryst Pharmaceuticals Inc Stock (BCRX) Price Forecast for 2028
In 2028, Biocryst Pharmaceuticals Inc (BCRX) is projected to reach an average price of $8.7037, with a high projection of $12.71 and a low estimate of $4.6952. This indicates an +1.32% rise from the last price of $8.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.67 | $11.01 | $12.71 | +35.88% |
| February, 2028 | $10.22 | $9.6461 | $11.71 | +18.99% |
| March, 2028 | $10.99 | $10.13 | $12.13 | +27.99% |
| April, 2028 | $9.9436 | $8.7994 | $11.86 | +15.76% |
| May, 2028 | $9.1374 | $8.0426 | $11.16 | +6.37% |
| June, 2028 | $8.1064 | $7.2516 | $9.7719 | -5.63% |
| July, 2028 | $8.0354 | $7.8554 | $8.8211 | -6.46% |
| August, 2028 | $6.0391 | $5.5691 | $8.1601 | -29.70% |
| September, 2028 | $6.4481 | $5.6786 | $6.5431 | -24.93% |
| October, 2028 | $6.3472 | $4.9776 | $6.8522 | -26.11% |
| November, 2028 | $6.1609 | $5.6214 | $6.7214 | -28.28% |
| December, 2028 | $4.8699 | $4.6952 | $6.7757 | -43.31% |
Biocryst Pharmaceuticals Inc Stock (BCRX) Price Forecast for 2029
The 2029 price forecast for Biocryst Pharmaceuticals Inc Stock (BCRX) is $3.2695 on average, with a high prediction of $5.7989 and a low estimate of $0.74. This represents an -61.94% decrease from the previous price of $8.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.2437 | $4.6547 | $5.7989 | -38.96% |
| February, 2029 | $5.1127 | $4.4832 | $5.7284 | -40.48% |
| March, 2029 | $4.7417 | $4.5717 | $5.2972 | -44.80% |
| April, 2029 | $3.8507 | $3.7207 | $5.7163 | -55.17% |
| May, 2029 | $2.9145 | $2.7595 | $4.5147 | -66.07% |
| June, 2029 | $4.1035 | $2.8192 | $4.1235 | -52.23% |
| July, 2029 | $3.9625 | $2.9382 | $4.543 | -53.87% |
| August, 2029 | $3.2962 | $3.2462 | $5.732 | -61.63% |
| September, 2029 | $3.7252 | $2.9307 | $4.3605 | -56.63% |
| October, 2029 | $3.049 | $2.8492 | $4.06 | -64.51% |
| November, 2029 | $2.488 | $2.328 | $3.3837 | -71.04% |
| December, 2029 | $1.25 | $0.74 | $2.8423 | -85.45% |
Biocryst Pharmaceuticals Inc Stock (BCRX) Price Forecast for 2030
Biocryst Pharmaceuticals Inc Stock (BCRX) is expected to reach an average price of $2.4322 in 2030, with a high forecast of $4.3349 and a low forecast of $0.5295. This signifies an -71.69% decrease from the last price of $8.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2075 | $0.5295 | $3.0515 | -62.66% |
| February, 2030 | $2.9295 | $2.994 | $2.8185 | -65.90% |
| March, 2030 | $3.4515 | $3.215 | $3.2765 | -59.82% |
| April, 2030 | $3.5584 | $3.907 | $3.7579 | -58.57% |
| May, 2030 | $3.5459 | $3.4488 | $3.2389 | -58.72% |
| June, 2030 | $4.0479 | $3.8714 | $3.9429 | -52.88% |
| July, 2030 | $4.0154 | $4.3739 | $4.3349 | -53.26% |
| August, 2030 | $3.0624 | $3.3324 | $3.5906 | -64.35% |
| September, 2030 | $3.1144 | $3.0689 | $2.9979 | -63.74% |
| October, 2030 | $3.4418 | $3.3714 | $3.2318 | -59.93% |
| November, 2030 | $4.0438 | $3.2583 | $3.1323 | -52.92% |
| December, 2030 | $4.1958 | $4.2553 | $4.1358 | -51.15% |
0.18%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):